Furthermore, in the PPI partners co-identified with the surrogate genes, ESR1 (estrogen receptor 1) is a widely known therapeutic target (for selective modulators, e.g. Raloxifene, Tamoxifen, etc.)in breast cancer in female [48]; however, its roles in the prostate cancer in male have not been revealed. Here, ESR1 is linked to prostate carcinoma.